Eko Murmur Analysis Software (EMAS) vs AVIEW
AI Verdict
Choose Eko Murmur Analysis Software (EMAS) if…
Choose Eko Murmur Analysis Software (EMAS) if you are a clinician, particularly in primary care or pediatrics, needing immediate, AI-powered assistance at the point of care for detecting and differentiating heart murmurs. This tool is ideal for enhancing auscultation with digital stethoscopes to provide early clinical decision support for potential heart and lung conditions.
View Eko Murmur Analysis Software (EMAS) →Choose AVIEW if…
Choose AVIEW if you are a radiologist or specialist requiring comprehensive, AI-driven analysis of CT scans for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification. This platform excels in detailed quantification of lung nodules, emphysema, and coronary artery calcium scoring, streamlining radiology workflows and providing advanced 3D visualizations for complex cases.
View AVIEW →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Murmur Analysis Software (EMAS) | AVIEW |
|---|---|---|
| Pricing | Starts at $119.99 per year for eko+ membership; enterprise solutions require contacting sales. | Subscription; one-off payment |
| Deployment | Cloud-based, Mobile App | Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker) |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Murmur Analysis Software (EMAS)Eko Murmur Analysis Software (EMAS) offers a more immediate and potentially intuitive user experience due to its mobile application and direct integration with a digital stethoscope for point-of-care diagnostics. AVIEW, while powerful for radiology workflows, likely involves a steeper learning curve given its comprehensive imaging analysis and integration requirements within complex IT environments.
Clinical Value
AVIEWAVIEW provides a broader and deeper diagnostic impact by analyzing multiple critical pathologies, including lung cancer, COPD, and coronary artery calcification, from complex CT scans. This comprehensive quantitative analysis and workflow integration offer significant value across several high-burden diseases, potentially impacting patient management more broadly than EMAS's focused murmur detection.
Pricing & Value
Eko Murmur Analysis Software (EMAS)EMAS offers a significant advantage with its free basic AI analysis, lowering the barrier to entry and providing immediate value to users. Its tiered subscription model allows for scalable access to advanced features, whereas AVIEW's pricing model is less transparent and lacks a free entry point.
Enterprise Readiness
AVIEWAVIEW demonstrates superior enterprise readiness with its flexible deployment options, including cloud, hybrid, local hardware, and virtualized solutions. Its explicit integration with PACS/RIS/CIS is crucial for seamless adoption into existing radiology and hospital IT infrastructures, offering greater adaptability than EMAS's mobile app-centric cloud deployment.
Innovation
AVIEWAVIEW showcases broader innovation by applying AI to analyze multiple complex pathologies (lung cancer, COPD, CAD, ILD) from a single CT scan, offering advanced features like 3D visualization and automated segmentation. While EMAS innovates at the point of care, AVIEW's comprehensive and multi-faceted approach to diagnostic imaging represents a deeper application of AI in complex medical analysis.
Support & Docs
TieBoth companies appear to offer standard support channels and documentation resources, including FAQs and contact options, as indicated by their respective websites. Without more specific details on the depth, quality, or accessibility of their support and documentation, it is not possible to definitively distinguish between the two.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Murmur Analysis Software (EMAS) | AVIEW |
|---|---|---|
| Name | Eko Murmur Analysis Software (EMAS) | AVIEW |
| Description | Eko Murmur Analysis Software (EMAS) is an FDA-cleared AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease. | Coreline Soft's AVIEW AI platform offers comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows. |
| Company | Eko Devices | Coreline Soft Co. |
| Primary AI Focus | FDA-cleared AI for murmur detection; Analyzes heart sound (PCG) and optional ECG data; Differentiates innocent and structural heart murmurs. | AI-powered lung nodule detection and characterization; Emphysema quantification and low attenuation area (LAA) analysis; Coronary artery calcium (CAC) scoring. |
| Target Specialties | Cardiology, Internal Medicine, Pediatrics | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Eko Murmur Analysis Software (EMAS) and AVIEW.